SUN PHARMA – Walk-In Interviews on 16th Aug’ 2022

Join Telegram

Sun Pharmaceutical Industries Limited is the world’s largest specialty generic pharmaceutical corporation. We provide high-quality, low-cost medicine that is trusted by healthcare professionals and patients worldwide. By market capitalization, it is also India’s largest, most trusted, and most valuable pharmaceutical company. To keep up with our expansion plans, we need young and energetic API plant candidates in Panoli, Gujarat.

SUN PHARMA – Walk-In Interviews on 16th Aug’ 2022

Sun Pharmaceutical Industries Ltd, Walk-in Interview at Panoli on 16th August 2022

Department Name: Production
Division: API
Position: Officer/ Sr. Officer / Technician
Qualification: B.Sc / M.Sc Diploma-Engineering / ITI
Experience Required: 03 to 06 years

Candidates for all of the above positions should have experience working in regulated plants such as USFDA, EU GMP, and WHO GMP.
Interested candidates should bring their most recent resume, a photograph, and a salary supporting letter with a component breakdown (Latest Increment Letter / Revised Salary Letter / Appointment Letter).


Interview Date: 16th August 2022

Time: 10:00AM to 3:00PM

Interview Venue: Sun Pharmaceutical Industries Ltd Panoli

Plot No – 24/2 & 25 Phase IV, GIDC Industrial Estate, Panoli – 394116, Dist. Bharuch

Related Jobs: Hetero Lab Walk-in Interview for Fresher (API unit)

Note: Sun Pharma does not solicit payment of any kind from prospective employees or authorize any agency or individual to collect or charge any fees or charges for recruitment. Please be cautious when dealing with any recruitment agency or anyone who asks you to pay money to represent Sun Pharma.

Leave a Comment

Your email address will not be published.

Join Telegram

Get Direct Jobs Notification

This will close in 15 seconds

Granules India Pvt. Limited-Walk-In Interviews 10 Largest Pharmaceutical Companies in USA List of the Best Paying Jobs in the Healthcare Industry USA. Lupin Biotech Limited -Walk-In Drive on 21, Aug 2022 Zydus receives Form 483 from the USFDA for 4 observations. क्या पैन किलर आपकी kidney को मार रही है? SUN PHARMA – Walk-In Interviews for Pharma candidates Purdue Pharma, Sacklers reach $6 billion deal USA